A novel variant of acute myelomonocytic leukemia carrying t(3;12)(q26;p13) with characteristics of 3q21q26 syndrome

International Journal of Hematology

Volumn 67, Issue 4, 1998, Pages 361-368

  Iwase, Satsuki ^a,b   Furukawa, Yusuke ^b   Horiguchi Yamada, Junko ^a   Nemoto, Tadashi ^a   Takahara, Shinobu ^a   Kawano, Takeshi ^a   Sekikawa, Tetsuaki ^a   Ito, Kiyoshi ^a   Yamazaki, Yasunori ^a   Kikuchi, Jiro ^b,c   Morishita, Kazuhiro ^d   Yamada, Hisashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Hitachi Koki Co Ltd   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

3q21q26 Syndrome; EVI1; T(3; 12); TEL

Indexed keywords

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; CASE REPORT; CHROMOSOME 3Q; CHROMOSOME TRANSLOCATION 3; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECIPROCAL CHROMOSOME TRANSLOCATION; SOUTHERN BLOTTING; THROMBOCYTOPOIESIS;

EID: 0031819393     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00022-x     Document Type: Article

References (24)

1. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
2. Bitter M.A., Neilly M.E., Le Beau M.M., Pearson M.G., Rowley J.D. Rearrangements of chromosome 3 involving band 3q21 and 3q26 are associated with normal or elevated platelet counts in acute non-lymphocytic leukemia. Blood. 66:1985;1362-1370.
3. Grigg A.P., Gascoyne R.D., Phillips G.L., Horsman D.E. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol. 83:1993;158-165.
4. Cline M.J. The molecular basis of leukemia. N Engl J Med. 330:1994;328-336.
5. Morishita K., Parganas E., Douglas E.C., Ihle J.N. Unique expression of the human Evi1 gene in an endometrial carcinoma cell line: sequence of cDNA and structure of alternatively spliced transcripts. Oncogene. 5:1990;963-971.
6. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316.
7. Yamada H., Ochi K., Nakada S., Takahara S., Nemoto T., Sekikawa T., Yamada J.H. Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells. Mol Cell Biochem. 152:1995;149-158.
8. Dalla-Favera R., Bregni M., Erickson J., Patterson D., Gallo R.C., Croce C.M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA. 79:1982;7824-7827.
9. Motokura T., Bloom T., Kim H.G., Jüppner H., Ruderman J.V., Kronenberg H.M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:1991;512-515.
10. Morishita K., Parganas E., Willman C.L., Whittaker M.H., Drabkin H., Oval J., Taetle R., Valentine M.B., Ihle J.M. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA. 89:1992;3937-3941.
11. Fichelson S., Dreyfus F., Berger R., Melle J., Bastard C., Miclea J.M., Gisselbrecht S. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosome region. Leukemia. 6:1992;93-99.
12. Ogawa S., Kurokawa M., Tanaka T., Tanaka K., Mitani K., Inazawa J., Hangaishi A., Tanaka K., Matsuo Y., Minowada J., Tsubota T., Yazaki Y., Hirai H. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene. 13:1996;183-191.
13. Morishita K., Parker D.S., Mucenski M.L., Jenkins N.A., Copeland N.G., Ihle J.N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell. 54:1988;831-840.
14. Morishita K., Parganas E., Parham D., Matsugi T., Ihle J.N. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. Oncogene. 5:1990;1419-1423.
15. Morishita K., Parganas E., Matsugi T., Ihle J.N. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol. 12:1992;183-189.
16. Kreider B.L., Orkin S.H., Ihle J.N. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid transforming gene. Proc Natl Acad Sci USA. 90:1993;6454-6458.
17. Papadopoulos P., Ridge S.A., Boucher C.A., Stocking C., Wiedemann L.M. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 55:1995;34-38.
18. Buijs A., Sherr S., van Baal S., van Bezouw S., van der Plas D., van Kessel A.G., Riegman P., Deprez R.L., Zwarthoff E., Hagemeijer A., Grosveld G. Translocation (12;22)(p13;q11) in myeloproliferative disorders in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene. 10:1995;1511-1519.
19. Romana S.P., Mauchauffe M., Le Coniat M., Chumakov I., Le Paslier D., Beger R., Bernard O.A. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 85:1995;3662-3670.
20. Suzukawa K., Parganas E., Gajjar A., Abe T., Takahashi S., Tani K., Asano S., Asou H., Kamada N., Yokota J., Morishita K., Ihle J.N. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood. 84:1994;2681-2688.
21. Massaad L., Prieur M., Leonard C., Dutrillaux B. Biclonal chromosome evolution of chronic myelomonocytic leukemia in a child. Cancer Genet Cytogenet. 44:1990;131-137.
22. Mozziconacci M.J., Brunel V., Sainty D., Arnoulet C., Gabert J., Simonetti J., Lafage-Pochitaloff M. Translocation (3;12)(q26.2;p13.1) dans des hémopathies myéloïdes: une nouvelle entité (abstract). Nouv Rev Fr Hématol. 37:1995;48.
23. Raynaud S.D., Baens M., Grosgeorge J., Rodgers K., Reid C.D.L., Dainton M., Dyer M., Fuzibet J.G., Gratecos N., Taillan B., Ayraud N., Marynen P. Fluorescence in situ hybridization analysis of t(3;12)(q26;p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood. 88:1996;682-689.
24. Peeters P., Wlodarska I., Baens M., Criel A., Selleslag D., Hagemeijer A., Van den Berghe H., Marynen P. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Res. 57:1997;564-569.